Ryanair to Cut Capacity at Berlin Airport, Citing High Costs
By Pierre Bertrand
Ryanair Holdings said it would cut 20% of its capacity at Berlin Brandenburg Airport due to high access costs.
The low-cost Irish airline said it would reduce the number of its aircraft based in the German capital to seven from nine, resulting in 750,000 fewer seats for passengers.
The airport will also lose six routes as Ryanair chooses to focus on lower-cost countries like Italy, Poland and Spain, the airline said.
Europe's largest carrier by passenger numbers said neither the airport nor the German government had addressed what it said were high access costs.
"At a time when Berlin should be growing, Ryanair is left with no choice but to cut capacity by 20% due to these sky-high air access costs," Ryanair airline boss Eddie Wilson said.
The company said last week that it would cut its capacity in Germany for summer next year by 10% if costs, including aviation taxes and air-traffic control charges, weren't reduced.
Germany increased its aviation taxes in May. Ryanair said Tuesday that the airport's air-traffic control charges have more than doubled since 2019 while the security fee cap is set to increase from next year.
Berlin Brandenburg Airport didn't immediately respond to a request for comment.
Write to Pierre Bertrand at pierre.bertrand@wsj.com
(END) Dow Jones Newswires
August 27, 2024 06:20 ET (10:20 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks